We review studies that propose follicle-stimulating hormone (FSH) as a physiologic stimulator of osteoclastic bone resorption. We hypothesize that, in addition to low estrogen, a rising FSH contributes to the increased bone resorption and bone loss in hypergonadism. This is of particular relevance to the perimenopausal transition, wherein profound bone loss is accompanied by trabecular perforations in the face of high FSH and normal estrogen levels. Potential therapeutic implications include the development of antagonists to both circulating FSH and its osteoclastic receptor.
Proresorptive Actions of FSH and Bone Loss. Publishing Authors By Initials
Proresorptive Actions of FSH and Bone Loss. Journal Published:
PUBLICATION TYPE: Journal Article
Journal: Annals of the New York Academy of Sciences
VOLUME: 1116
Page Numbers: 376-82
Journal Abbreviation: Ann. N. Y. Acad. Sci.
ISSN: 0077-8923
DAY: 17
MONTH: Dec
YEAR: 2007
Proresorptive Actions of FSH and Bone Loss. Information
Number of References:
LANGUAGE: eng
NlmUniqueID: 7506858
Proresorptive Actions of FSH and Bone Loss. Keywords Mesh Terms:
KEYWORDS:
MESH TERMS:
Chemical & Substance for Abstract: Proresorptive Actions of FSH and Bone Loss. Information
Substance Name:
Registry Number:
Grant and Affiliation Information for Proresorptive Actions of FSH and Bone Loss.
AFFILIATION: The Mount Sinai School of Medicine, Division of Endocrinology, Box 1055, One Gustave L. Levy Place, Atran Building AB4-02, New York, NY 10029. Li.sun@mssm.edu.
Country: United States
AGENCY:
GRANT:
ACRONYM:
MEDLINETA: Ann N Y Acad Sci
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
Proresorptive Actions of FSH and Bone Loss Related Publications